HDAC9 and plasma cell myeloma: The first combination (Figure 1B) targeted the CDK family, AKT1 and HDAC family driver targets of the LP1 myeloma cell line, while the second combination affected the CDK family, the MEK1/2 complex and NOTCH via gamma secretase.